For decades, artificial intelligence advanced in careful, mostly linear steps. Researchers built models. Engineers improved performance. Organizations deployed systems to automate specific tasks. Each ...

Why Recursion Pharmaceuticals Is On Investors’ Radar Recursion Pharmaceuticals (RXRX) has been drawing attention after recent trading, with the stock closing at $4.67. Investors are weighing this ...

Many in the AI community believe that the next major revolution will be the era of self-improving AI where AI can improve itself without human intervention. The argument is: as models grow more ...

1. Long-Context Reasoning: Recursive language models (RLMs) now enable reasoning over effectively unlimited context, ...

Many nonprofits in low- and middle-income countries face a critical mismatch: urgent social problems demand rapid program iteration, yet organizations often wait years for externally-produced ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation. “GPT-5.3-Codex is our first model that was instrumental in creating itself,” ...

The go-to-market AI sector has become one of the most crowded verticals in enterprise software. Companies like Gong and Clari now compete alongside dozens of well-funded startups, all pursuing the ...